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raveler’s rickettsioses and domestic rickettsioses in Japan in
011
. Ando ∗, Y. Ogasawara
National Institute of Infectious Diseases, Tokyo, Japan
Background: Various rickettsioses distribute worldwide. Scrub
yphus and Japanese spotted fever are known in Japan. Each rick-
ttsiosis is reported about 400 cases and over 100 cases every year
nd has seasonal and geographical characteristics. In contrast, trav-
ler’s rickettsioses are febris acute diseases to need attention for
ll season and nationwide. In 2011, we experienced a laboratory
iagnosis of various rickettsioses.
Methods: In many time, untypical cases and imported cases are
equested to perform laboratory diagnosis for our laboratory. We
erformedseveral PCR tests, targeteddifferent reckettsial sequence
egions, and measure antibody titer. We detected a rickettsial spe-
iﬁc gene from acute phase samples (eschars, skin biopsy of rash
ndwhole blood) and conﬁrmedantibody titers elevationbypaired
era.
Results: ThreeAfrican tick bite fever caseswere diagnosed (case
traveled to Swaziland and case 2 to South Africa in January, and
ase 7 traveled to Zimbabwe and Botswana in December). Case
was forgrin traveler from South Africa, and diagnosed as Bou-
onnese fever. Case 5 was Scrub typhus who traveled to Malaysia
n March. Case 6 was murine typhus, who stayed in Thailand and
howed acute respiratory disorder syndrome in April. On the other
and, case 4 was suggested as the new spotted fever group Rick-
ttsia by results of genetic sequence analysis of PCR products and
howed antibody elevation against Rickettsia conorii.
Conclusion: Antigenic cross-reactivity are high among spot-
ed fever rickettsia group, there is a limit for differentiation of
nfected Rickettsia species by serologic diagnosis. In addition,mem-
ers of spotted fever group Rickettsia have increased until now.
potted fever rickettsioses show variety in clinical symptom, and
ave various outbreak situation anddistribution. Therefore, history
nd episodes of the patients before onset are extremely impor-
ant. In this presentation,we summarize traveler’s rickettsioses and
omestic rickettsioses in 2011 in Japan.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.398
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linical study on efﬁcacy and safety of piperamisinin
dihydroartemisinin-piperaquine) in uncomplicated falci-
arum malaria
.M. Hlaing ∗, K.Z. Oo, K.P. PyarDirectorate of Medical Services, Nay Pyi Taw, Myanmar
Background: Dihydroartemisinin and piperaquine phosphate
o-formulated tablets manufactured from Pharmaceutical Com-fectious Diseases 16S (2012) e317–e473 e337
panies of Republic of China namely Artekin and Artepip had
been studied in Clinical Research Unit (Malaria) No. (1) DSGH
(1000-Beds) Mingalardon in 2006-2008 for the treatment of
uncomplicated falciparum malaria and it was found to be safe
and effective. Piperamisinin, a combined tablet, containing 50mg
dihydroartemisinin and350mgpiperaquinephosphate, is ﬁrst pro-
duced from Myanmar Pharmaceutical Factory (MPF) of Ministry of
Industry in 2009.
Methods: An hospital based clinical study following 28 days
WHO standard therapeutic efﬁcacy test was conducted at 1000
Bedded Hospital in Mingalardon, Yangon Division, 300 Bedded
Hospital in Myitkyinar, Kachin State and 100 Bedded Hospital in
Lashio, Shan State on a total of 23 patients with acute uncom-
plicated falciparum malaria between March to October 2010, to
study the effectiveness, tolerability and safety of piperamisinin. The
patients who met the inclusion criteria were given Piperamisinin
combined tablets with the dosage of 3 tablet at 0-Hr, 24-Hr & 48-
Hr. The patientswere thoroughly assessed andmonitored clinically
including ECG, parasitologically, haematologically, and biochemi-
cally (Blood sugar, urea & serum creatinine) for side effects during
the 28 days of conﬁnement at the respective hospitals.
Results: The participants were 29.52 years old on average and
ranged from 14 to 57 years of age. Initial parasitaemia was 1983.16
± 2685.45 per L whereas initial temperature was 37.8 ± 0.88
◦C. Fever clearance time (FCT) and parasite clearance time (PCT)
were 14.63 ± 10.72 hours 27.18 ± 11.44 hours respectively. Nei-
ther early treatment failurenor late treatment failurewasobserved.
Adequate clinical and parasitological response (ACPR) was 100
percents.There were no serious clinical or laboratory side effects
observed in the study.
Conclusion: In general, Domestically manufactured
Piperamisinin combined tablet is safe and effective for the
treatment of uncomplicated falciparum malaria patients in three
different states and divsion of Myanmar.
http://dx.doi.org/10.1016/j.ijid.2012.05.399
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Malaria and co-infection among traveller in a refferal hospital:
a case series
H. Habib1, S. Lardo2,∗
1 University of Indonesia, Jakarta, Indonesia
2 Gatot Subroto Central Army Hospital, Jakarta, Indonesia
Background:Areferral hospital in tropical regionoften received
referral malaria patient with many co infection undiagnosed and
haveno respon to the therapy fromthe local hospital. Becauseof the
indaquate therapy before, the referral patient usually have atypical
sign and symptoms.The epidemiology of infection from the region
where patient stay should take into consideration because patient
could have multiple infection.
Methods: Here we report a case series of three refferal patients
of Gatot Subroto Central ArmyHospital Jakarta, Indonesiawithmix
falciparum and vivax infection, falciparum and H1N1, vivax and
dengue.
Results:Case1wasamalepatientwith suddenonsetof continu-
oushighgrade fever for threedays.Hewasanarmyonduty referred
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rom local hospital in Papua, an endemic malaria region. He also
ad chilled and diaphoresis. The laboratory result was pancytope-
ia, positive IgM anti dengue, and positive vivax from peripheral
lood smear.
Case 2 was a male patient with ﬂu like illness for three day and
e just arrived from pantai gading an endemic malaria region, no
istory of animal contact but there was a pandemic of H1N1 ses-
ion. At presentation in referral hospital, his laboratory result was
ancytopenia. The laboratory result for oropharyngeal swab is pos-
tive for H1N1 infection, and his rapid malaria test was positive
alciparum.
Case 3 was a male patient with mixed malaria infection with
alciparum and vivax . The vivax parasite was detected on pheriph-
ral blood smear one month after ﬁnished falciparum treatment.
he vivax and falciparum parasite was undetected at ﬁrst presen-
ation in referral hospital due to kina treatment in local hospital,
ut the IDT for falciparum was (+) and the peripheral blood was
ancytopenia, patient was a traveler in East Borneo and never had
alaria before.
Conclusion: A Refferal hospital in Indonesia as one of tropical
ountry could have reffered patients with multiple infection with
ary clinical manifestation. One clinical condition could be more
rominent than other in one patient, lead to a miss in diagnostic.
careful examination, including taking information of history of
ravel, epidemiology, and complete laboratory examination could
etect the other hidden infection.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.400
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ovel spotted fever group rickettsiosis? in a Japanese traveler
eturned from India
. Takajo1,∗, M. Matsuda1, Y. Kariya1, S. Sakaguchi1, T.
awagichi1, S. Miyauchi1, K. Umekita1, S. Ueno1, N. Kusumoto1,
. Nagatomo1, Y. Ogasawara2, S. Ando2, A. Okayama1
University of Miyazaki, Miyazaki City, Japan
National Institute of Infectious Diseases, Tokyo, Japan
Background: Various spotted fever group rickettsioses dis-
ribute worldwide, and cause human acute febrile illness.
ickettsioses are important as traveler’s infectious diseases. We
xperienced a rickettsiosis of Japanese returned from India.
Methods: (Case presentation)A 66 years-old female traveled to
outh part of India for a week. Next day returned, she complained
eneral malaise and anorexia. On day 7 after onset, she developed
fever and showed skin rash, and saw a local doctor. Splenoma
as recognized by the abdominal echo examination. At that time,
aboratorydata showed thrombocytopenia (9.1 x1010/L), liver dys-
unction (AST 92 IU/L, ALT 97 IU/L), and elevation of C-reactive
rotein (20.6 mg/dL). She admitted to our hospital from a local
octor.
Results: Fever and laboratory abnormalities improved by the
reatment with levoﬂoxacin and ceftriaxone. However, the skin
etechial rash and edema of both legs continued. Malaria, typhoid
ever, dengue and chikungunya fever were negative by speciﬁc
ests. On the other hand, IgG antibodies to Rickettsia conorii
alish 7 and Rickettsia japonica YH elevated with paired serafectious Diseases 16S (2012) e317–e473
and rickettsiosis was suspected. She was treated with minocy-
cline in addition and her residual symptoms disappeared. Using
stored whole blood of acute phase, PCR was performed for sev-
eral rickettsial genes. Only ompA-targeted PCR showed positive.
Its sequence was identical with Rickettsia sp. CMCMICRO, of which
ompA sequences were partially registered in 2010.
Conclusion: A novel rickettsiosis was diagnosed in a Japanese
traveler patient returned from India. This rickettsiosis showed
mild clinical course without speciﬁc antibiotic treatment, although
some symptoms remained. Even now, it is possible that unknown
rickettsioses distribute worldwide. The information of this detect-
edRickettsiasp. is limited. Therefore, it is need to isolate from
patients for additional analysis.
http://dx.doi.org/10.1016/j.ijid.2012.05.401
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Epidemiology of malaria-intestinal helminth co-infection
among children and adults in Ona-ara local government area,
Oyo state
C. Afonne1,∗, I. Ajayi1, H. Dada-adegbola2, F. Oshiname3, C.
Falade3
1 UNIVERSITY OF IBADAN, NIGERIA, Ibadan, OY, Nigeria
2 University college hospital, ibadan, Ibadan, OY, Nigeria
3 UNIVERSITY OF IBADAN, NIGERIA, Ibadan, OY, Nigeria
Background: Co-infection of malaria-causing parasites with
intestinal helminths is a public health concern and has not been
fully explored in Nigeria.
Methods: A cross-sectional survey was conducted among 641
consenting household heads, questions were based on demo-
graphics, household environment/hygiene, malaria/helminthiasis
prevention practices. Single stool and/or ﬁnger prick blood sam-
pleswere collected from341 children (6months-13 years) and 678
adults (≥14 years). Kato-Katz and formol-ether techniques were
carried out on stool samples before microscopy; Giemsa-stained
thick blood smears were used to screen for malaria parasites. Sub-
sequently, 211 consenting asymptomatic individuals with patent
malaria parasitaemia, irrespective of the presence or absence of
intestinal helminth, were followed until they developed acute
malaria or follow up period elapsed (6 weeks). Data were ana-
lyzed using descriptive statistics, Chi-square, Logistic regression,
Kaplan-Meier and Log-rank statistic.
Results: Mean age of household heads was 46.0 ± 1.3 years,
9% used mosquito nets, 50% managed malaria at home ﬁrst before
visiting other health care providers. Many (55.7%) used drugs
to prevent worm infection; (21.0%) used herbs while 23.3% did
not practice deworming. The mean age of children and adults
tested were 5.9 ± 0.68 and 45.1 ± 2.5 respectively.Prevalence of
asymptomatic malaria, intestinal helminth infections and malaria-
intestinal helminth co-infection were 26.7%, 22.1%, and 13.9%
respectively. Ascaris lumbricoides (94.0%), Strongyloides stercoralis
(2.0%), Hookworm (2.0%), Trichuris trichuria (1.0%) and Enterobius
vermicularis (1.0%) were identiﬁed. Children were more likely to
be co-infected than adults (OR=2.7; CI = 1.1 - 6.6). Children whose
head of household had no education were more likely to be co-
infected than those whose head of household had were educated
